IA
PHAT icon

IFP Advisors’s Phathom Pharmaceuticals PHAT Stock Holding History

IFP Advisors’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11 Hold
1
– – ﹤0.01% 4962
2025
Q4 		$17 Buy
+1
New +$14 ﹤0.01% 4815
2025
Q3 		– Sell
-11
Closed -$105 – 4906
2025
Q2 		$105 Buy
11
+9
+450% +$50 ﹤0.01% 4728
2025
Q1 		$13 Hold
2
– – ﹤0.01% 4211
2024
Q4 		$16 Buy
+2
New +$25 ﹤0.01% 4486
2023
Q1 		– Sell
-6
Closed -$1K – 4156
2022
Q4 		$1K Sell
6
-56
-90% -$577 ﹤0.01% 4437
2022
Q3 		$2K Buy
62
+6
+11% +$57 ﹤0.01% 4390
2022
Q2 		$1K Hold
56
– – ﹤0.01% 4413
2022
Q1 		$1K Buy
+56
New +$905 ﹤0.01% 4411

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return